Hepatitis SA, 6 September 2016
A clinical trial is now open for people who have been diagnosed with chronic Hepatitis B Virus (HBV) infection, who have not had treatment for this condition in the last 2 years. Other entry requirements apply.
The purpose of this research study is to assess the effectiveness and safety of a novel medicine for the treatment of patients with chronic Hepatitis B. Participating clinics include leading hospitals and medical centres.
If you live in South Australia, and are interested to participate, contact the Study Coordinators at the Royal Adelaide Hospital.
Read more here